title: Panel advises against rimonabant approval.
authors.forename: Kate
authors.initials: K
authors.lastname: Traynor
mesh_terms: D026683:Advisory Committees / Q000331:legislation & jurisprudence*; D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D009765:Obesity / Q000188:drug therapy / Q000523:psychology; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077285:Rimonabant; D014481:United States
chemical_list: D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant